|Articles|June 5, 2019

Moderate-monovision outcomes see improvement with small aperture IOLs

Dr Jacqueline Beltz, FRANZCO, shares the take-home message from her 2019 ASCRS presentation

Dr Jacqueline Beltz, FRANZCO, shares the key takeaways from her presentation, "Comparison of Moderate-Monovision with Monofocal Intraocular Lenses versus Mini-Monovision with a Small Aperture Intraocular Lens," which she delivered at the annual 2019 ASCRS meeting in San Diego.

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related to this article

Injection Image Credit: AdobeStock/Romas_ph

June 24th, 2026

Bayer acquires Perfuse Therapeutics, partners with Iambic to expand ophthalmology and AI capabilities

Bayer acquired Perfuse Therapeutics and its experimental endothelin-blocking eye implant PER-001, and partnered with AI firm Iambic Therapeutics to accelerate small molecule drug discovery.

June 18th, 2026

IOLs: What Every Surgeon Needs to Know | Ep. 2: Enhanced monofocal IOLs

Douglas D. Koch, MD, and Karolinne Maia Rocha, MD, PhD, discuss the optics behind enhanced monofocal lenses, patient selection, and how to set expectations.

Moderate-monovision outcomes see improvement with small aperture IOLs

Related to this article

Trending on Eye Care Network - Ophthalmology Times

Brepocitinib meets all Phase 3 end points in noninfectious uveitis

Matching artificial tears to dry eye phenotype: a Q&A with Omur Ucakhan, MD

Demodex blepharitis: Diagnosis, treatment response, and recurrence

Myopia control using spectacle lenses with highly aspherical lenslets

SpyGlass Pharma's BIM-IOL System holds 37% IOP reduction at 4 years in first-in-human trial